Supramolecular metal-organic frameworks as host-guest nanoplatforms for versatile and customizable biomedical applications
Bibliographic record
Abstract
No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.
Source: Not provided · Quality: missing
Research context
OpenAlex topics: Metal-Organic Frameworks: Synthesis and Applications · Nanoplatforms for cancer theranostics · Nanoparticle-Based Drug Delivery
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (46)
Show source-provided references
1. Personalized nanomedicine10.1158/1078-0432.CCR-12-1414 ↗
2. Renal clearable theranostic nanoplatforms for gastrointestinal stromal tumors10.1002/adma.201905899 ↗
3. Multifunctional nanoparticles for drug delivery and molecular imaging10.1146/annurev-bioeng-071812-152409 ↗
4. Massively parallel pooled screening reveals genomic determinants of nanoparticle delivery10.1126/science.abm5551 ↗
5. Multifunctional biomolecule nanostructures for cancer therapy10.1038/s41578-021-00315-x ↗
6. Engineering precision nanoparticles for drug delivery10.1038/s41573-020-0090-8 ↗
7. Multifunctional nanoparticles: cost versus benefit of adding targeting and imaging capabilities10.1126/science.1226338 ↗
8. Association between gadolinium contrast exposure and the risk of parkinsonism10.1001/jama.2016.8096 ↗
9. The SNMMI practice guideline for therapy of thyroid disease with 131I 3.010.2967/jnumed.112.105148 ↗
10. A programmable polymer library that enables the construction of stimuli-responsive nanocarriers containing logic gates10.1038/s41557-020-0426-3 ↗
11. Bioresponsive materials10.1038/natrevmats.2016.75 ↗
12. Biodegradable iodinated polydisulfides as contrast agents for CT angiography10.1016/j.biomaterials.2014.03.054 ↗
13. Prodrugs forming high drug loading multifunctional nanocapsules for intracellular cancer drug delivery10.1021/ja909475m ↗
14. Probing multivalent interactions in a synthetic host-guest complex by dynamic force spectroscopy10.1021/ja2016125 ↗
15. Polyrotaxane-based supramolecular theranostics10.1038/s41467-018-03119-w ↗
16. Metal-organic frameworks from edible natural products10.1002/anie.201002343 ↗
17. CelluMOFs: green, facile, and flexible metal-organic frameworks for versatile applications
18. Nanoscale metal-organic frameworks for biomedical imaging and drug delivery10.1021/ar200028a ↗
19. Biocompatible cyclodextrin-based metal–organic frameworks for long-term sustained release of fragrances
20. Cyclodextrin metal-organic frameworks and derivatives: recent developments and applications10.1039/D1CS00550B ↗
21. Pulmonary targeting crosslinked cyclodextrin metal–organic frameworks for lung cancer therapy
22. Synthesis and structure of new carbohydrate metal-organic frameworks and inclusion complexes10.1016/j.molstruc.2015.08.020 ↗
23. A targeted nanoglobular contrast agent from host-guest self-assembly for MR cancer molecular imaging10.1016/j.biomaterials.2016.02.002 ↗
24. The effect of nanoparticle size on in vivo pharmacokinetics and cellular interaction10.2217/nnm.16.5 ↗
25. Principles of nanoparticle design for overcoming biological barriers to drug delivery10.1038/nbt.3330 ↗
26. Nonviral cancer gene therapy: delivery cascade and vector nanoproperty integration10.1016/j.addr.2017.07.021 ↗
27. Rational design of cancer nanomedicine: nanoproperty integration and synchronization10.1002/adma.201606628 ↗
28. Influence of particle size and shape on their margination and wall-adhesion: implications in drug delivery vehicle design across nano-to-micro scale10.1039/C8NR04042G ↗
29. Membrane wrapping efficiency of elastic nanoparticles during endocytosis: size and shape matter10.1021/acsnano.8b05340 ↗
30. Macroscopic self-assembly through molecular recognition10.1038/nchem.893 ↗
31. A targeted nanoglobular contrast agent from host-guest self-assembly for MR cancer molecular imaging10.1016/j.biomaterials.2016.02.002 ↗
32. Rotationally resolved infrared spectroscopy of adamantane10.1063/1.3666853 ↗
33. Effect of pegylation on pharmaceuticals10.1038/nrd1033 ↗
34. Brush conformation of polyethylene glycol determines the stealth effect of nanocarriers in the low protein adsorption regime10.1021/acs.nanolett.0c03756 ↗
35. Exploiting the dynamics of the EPR effect and strategies to improve the therapeutic effects of nanomedicines by using EPR effect enhancers10.1016/j.addr.2020.06.005 ↗
36. Transcytosis-enabled active extravasation of tumor nanomedicine10.1016/j.addr.2022.114480 ↗
37. MRI detection of breast cancer micrometastases with a fibronectin-targeting contrast agent10.1038/ncomms8984 ↗
38. Gadolinium-based contrast agents for magnetic resonance cancer imaging10.1002/wnan.1198 ↗
39. First multiparametric cardiovascular magnetic resonance study using ultrasmall superparamagnetic iron oxide nanoparticles in a patient with acute myocardial infarction10.1161/CIRCULATIONAHA.112.108167 ↗
40. Positive magnetic resonance angiography using ultrafine ferritin-based iron oxide nanoparticles10.1039/C8NR06812G ↗
41. Nanoparticle contrast agents for X-ray imaging applications10.1002/wnan.1642 ↗
42. Chemical structure and shape enhance MR imaging-guided X-ray therapy following marginative delivery10.1021/acsami.1c24991 ↗
43. Big potential from small agents: nanoparticles for imaging-based companion diagnostics10.1021/acsnano.7b07252 ↗
44. Gadolinium retention in the rat brain: assessment of the amounts of insoluble gadolinium-containing species and intact gadolinium complexes after repeated administration of gadolinium-based contrast agents10.1148/radiol.2017162857 ↗
45. Use of intravenous iodinated contrast media in patients with kidney disease: consensus statements from the American college of radiology and the national kidney foundation10.1148/radiol.2019192094 ↗
46. Peptide-targeted nanoglobular Gd-DOTA monoamide conjugates for magnetic resonance cancer molecular imaging10.1021/bm901352v ↗